Gabelli Healthcare & WellnessRx Trust
CIK: 0001391437
GRX
Equity
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | REGN Regeneron Pharmaceuticals, Inc. Since 2026-07-07 | 75886F107 | Equity (Common) |
0.77%
|
$1.13 | 1,465 |
| 2 | CRL Charles River Laboratories International, Inc. Since 2026-07-07 | 159864107 | Equity (Common) |
0.17%
|
$0.26 | 1,500 |
| 3 | TMO Thermo Fisher Scientific Inc Since 2026-07-07 | 883556102 | Equity (Common) |
0.95%
|
$1.40 | 2,845 |
| 4 | LNTH Lantheus Holdings Inc Since 2026-07-07 | 516544103 | Equity (Common) |
1.23%
|
$1.82 | 24,000 |
| 5 | CTMX Cytomx Therapeutics Inc Since 2026-07-07 | 23284F105 | Equity (Common) |
0.10%
|
$0.15 | 33,000 |
| 6 | BMY Bristol-Myers Squibb Company Since 2026-07-07 | 110122108 | Equity (Common) |
1.85%
|
$2.73 | 45,000 |
| 7 | JNJ Johnson & Johnson Since 2026-07-07 | 478160104 | Equity (Common) |
1.60%
|
$2.37 | 9,700 |
| 8 | HCA HCA Healthcare Inc Since 2026-07-07 | 40412C101 | Equity (Common) |
0.64%
|
$0.95 | 2,000 |
| 9 | BHC Bausch Health Companies Inc. Since 2026-07-07 | 071734107 | Equity (Common) |
0.06%
|
$0.10 | 17,500 |
| 10 | VTRS Viatris Inc Since 2026-07-07 | 92556V106 | Equity (Common) |
0.09%
|
$0.14 | 10,000 |
| 11 | ISRG Intuitive Surgical Inc. Since 2026-07-07 | 46120E602 | Equity (Common) |
0.62%
|
$0.92 | 2,000 |
| 12 | RVMD Revolution Medicines Inc Since 2026-07-07 | 76155X100 | Equity (Common) |
0.21%
|
$0.32 | 3,250 |
| 13 | ELMD Electromed Inc Since 2026-07-07 | 285409108 | Equity (Common) |
0.06%
|
$0.09 | 4,000 |
| 14 | RDNT Radnet Inc Since 2026-07-07 | 750491102 | Equity (Common) |
0.01%
|
$0.01 | 200 |
| 15 | CHD Church & Dwight Co Inc. Since 2026-07-07 | 171340102 | Equity (Common) |
0.76%
|
$1.12 | 12,000 |
| 16 | ALGN Align Technology Inc. Since 2026-07-07 | 016255101 | Equity (Common) |
0.06%
|
$0.09 | 500 |
| 17 | KR The Kroger Co. Since 2026-07-07 | 501044101 | Equity (Common) |
1.22%
|
$1.81 | 25,000 |
| 18 | BSX Boston Scientific Corporation Since 2026-07-07 | 101137107 | Equity (Common) |
0.25%
|
$0.38 | 6,000 |
| 19 | HQY Healthequity Inc Since 2026-07-07 | 42226A107 | Equity (Common) |
0.09%
|
$0.13 | 1,600 |
| 20 | TARS Tarsus Pharmaceuticals Inc Since 2026-07-07 | 87650L103 | Equity (Common) |
0.17%
|
$0.25 | 3,600 |
| 21 | RCEL Avita Medical Inc. Since 2026-07-07 | 05380C102 | Equity (Common) |
0.04%
|
$0.06 | 15,000 |
| 22 | UPB Upstream Bio Inc Since 2026-07-07 | 91678A107 | Equity (Common) |
0.00%
|
$0.00 | 400 |
| 23 | LUCD Lucid Diagnostics Inc Since 2026-07-07 | 54948X109 | Equity (Common) |
0.02%
|
$0.02 | 19,500 |
| 24 | COR Cencora Inc Since 2026-07-07 | 03073E105 | Equity (Common) |
2.23%
|
$3.30 | 10,500 |
| 25 | MEDP Medpace Holdings Inc. Since 2026-07-07 | 58506Q109 | Equity (Common) |
0.11%
|
$0.17 | 350 |
| 26 | LH Labcorp Holdings Inc Since 2026-07-07 | 504922105 | Equity (Common) |
1.37%
|
$2.02 | 7,570 |
| 27 | VKTX Viking Therapeutics Inc. Since 2026-07-07 | 92686J106 | Equity (Common) |
0.10%
|
$0.14 | 4,400 |
| 28 | INFU InfuSystem Holdings inc. Since 2026-07-07 | 45685K102 | Equity (Common) |
0.89%
|
$1.31 | 142,085 |
| 29 | VERA VERA THERAPEUTICS INC Since 2026-07-07 | 92337R101 | Equity (Common) |
0.07%
|
$0.10 | 2,500 |
| 30 | BBIO Bridgebio Pharma Inc Since 2026-07-07 | 10806X102 | Equity (Common) |
2.56%
|
$3.79 | 51,000 |
| 31 | MDGL Madrigal Pharmaceuticals Inc Since 2026-07-07 | 558868105 | Equity (Common) |
0.11%
|
$0.16 | 300 |
| 32 | APLS Apellis Pharmaceuticals Inc Since 2026-07-07 | 03753U106 | Equity (Common) |
0.27%
|
$0.40 | 10,000 |
| 33 | DHR Danaher Corporation Since 2026-07-07 | 235851102 | Equity (Common) |
0.01%
|
$0.01 | 50 |
| 34 | SJM The J M Smucker Company Since 2026-07-07 | 832696405 | Equity (Common) |
0.98%
|
$1.45 | 15,000 |
| 35 | CAH Cardinal Health, Inc. Since 2026-07-07 | 14149Y108 | Equity (Common) |
0.43%
|
$0.63 | 3,000 |
| 36 | CVGW Calavo Growers Inc Since 2026-07-07 | 128246105 | Equity (Common) |
0.09%
|
$0.13 | 5,000 |
| 37 | BIO.B Bio-Rad Laboratories, Inc. Since 2026-07-07 | 090572207 | Equity (Common) |
0.73%
|
$1.09 | 3,900 |
| 38 | CRNX Crinetics Pharmaceuticals Inc. Since 2026-07-07 | 22663K107 | Equity (Common) |
0.15%
|
$0.22 | 6,000 |
| 39 | ABT Abbott Laboratories Since 2026-07-07 | 002824100 | Equity (Common) |
1.19%
|
$1.77 | 17,200 |
| 40 | AZN AstraZeneca PLC Since 2026-07-07 | — | Equity (Common) |
2.21%
|
$3.27 | 16,600 |
| 41 | TVTX Travere Therapeutics Inc Since 2026-07-07 | 89422G107 | Equity (Common) |
0.09%
|
$0.13 | 4,300 |
| 42 | MDLN Medline Inc. Since 2026-07-07 | 58507V107 | Equity (Common) |
0.12%
|
$0.18 | 4,000 |
| 43 | HSIC Henry Schein, Inc. Since 2026-07-07 | 806407102 | Equity (Common) |
1.38%
|
$2.04 | 27,700 |
| 44 | BTSG BRIGHTSPRING HEALTH SERVICES INC Since 2026-07-07 | 10950A106 | Equity (Common) |
0.32%
|
$0.47 | 11,150 |
| 45 | MRK Merck & Co., Inc Since 2026-07-07 | 58933Y105 | Equity (Common) |
3.57%
|
$5.28 | 43,850 |
| 46 | TERN Terns Pharmaceuticals Inc. Since 2026-07-07 | 880881107 | Equity (Common) |
0.36%
|
$0.53 | 10,000 |
| 47 | XENE Xenon Pharmaceuticals Inc Since 2026-07-07 | 98420N105 | Equity (Common) |
0.12%
|
$0.17 | 3,000 |
| 48 | QURE Uniqure N.V. Since 2026-07-07 | — | Equity (Common) |
0.06%
|
$0.08 | 5,000 |
| 49 | WGS GeneDx Holdings Corp Since 2026-07-07 | 81663L200 | Equity (Common) |
0.00%
|
$0.00 | 50 |
| 50 | NEO Neogenomics Inc Since 2026-07-07 | 64049M209 | Equity (Common) |
0.45%
|
$0.67 | 90,000 |
| 51 | AXSM Axsome Therapeutics Inc. Since 2026-07-07 | 05464T104 | Equity (Common) |
0.11%
|
$0.17 | 1,000 |
| 52 | AMGN Amgen Inc. Since 2026-07-07 | 031162100 | Equity (Common) |
1.88%
|
$2.78 | 7,900 |
| 53 | VRTX Vertex Pharmaceuticals Incorporated Since 2026-07-07 | 92532F100 | Equity (Common) |
0.97%
|
$1.43 | 3,200 |
| 54 | ALHC Alignment Healthcare Inc Since 2026-07-07 | 01625V104 | Equity (Common) |
0.30%
|
$0.44 | 25,000 |
| 55 | THC Tenet Healthcare Corporation Since 2026-07-07 | 88033G407 | Equity (Common) |
1.26%
|
$1.87 | 9,900 |
| 56 | WAT Waters Corporation Since 2026-07-07 | 941848103 | Equity (Common) |
0.32%
|
$0.47 | 1,577 |
| 57 | ALKS Alkermes PLC Since 2026-07-07 | — | Equity (Common) |
0.12%
|
$0.18 | 5,000 |
| 58 | MDT Medtronic PLC Since 2026-07-07 | — | Equity (Common) |
0.70%
|
$1.04 | 12,000 |
| 59 | PRGO Perrigo Company PLC Since 2026-07-07 | — | Equity (Common) |
0.09%
|
$0.14 | 13,000 |
| 60 | BDX Becton, Dickinson and Company Since 2026-07-07 | 075887109 | Equity (Common) |
0.92%
|
$1.37 | 8,700 |
| 61 | OFIX Orthofix Medical Inc Since 2026-07-07 | 68752M108 | Equity (Common) |
0.10%
|
$0.14 | 12,500 |
| 62 | PTGX Protagonist Therapeutics Inc Since 2026-07-07 | 74366E102 | Equity (Common) |
0.18%
|
$0.26 | 2,500 |
| 63 | VCEL Vericel Corporation Since 2026-07-07 | 92346J108 | Equity (Common) |
0.17%
|
$0.26 | 8,000 |
| 64 | CI The Cigna Group Since 2026-07-07 | 125523100 | Equity (Common) |
2.49%
|
$3.68 | 13,800 |
| 65 | RGNX Regenxbio Inc. Since 2026-07-07 | 75901B107 | Equity (Common) |
0.00%
|
$0.00 | 100 |
| 66 | GILD Gilead Sciences Inc. Since 2026-07-07 | 375558103 | Equity (Common) |
0.42%
|
$0.63 | 4,500 |
| 67 | AVTR Avantor Inc Since 2026-07-07 | 05352A100 | Equity (Common) |
0.22%
|
$0.33 | 42,000 |
| 68 | DNLI Denali Therapeutics Inc Since 2026-07-07 | 24823R105 | Equity (Common) |
0.01%
|
$0.02 | 1,000 |
| 69 | BAX Baxter International, Inc. Since 2026-07-07 | 071813109 | Equity (Common) |
0.27%
|
$0.40 | 23,500 |
| 70 | COO The Cooper Companies, Inc. Since 2026-07-07 | 216648501 | Equity (Common) |
2.06%
|
$3.05 | 42,700 |
| 71 | DYN DYNE THERAPEUTICS INC Since 2026-07-07 | 26818M108 | Equity (Common) |
0.01%
|
$0.02 | 1,200 |
| 72 | POST Post Holdings Inc. Since 2026-07-07 | 737446104 | Equity (Common) |
1.87%
|
$2.77 | 28,000 |
| 73 | IMKTA Ingles Markets, Incorporated Since 2026-07-07 | 457030104 | Equity (Common) |
1.52%
|
$2.25 | 25,000 |
| 74 | WVE Wave Life Sciences Ltd. Since 2026-07-07 | — | Equity (Common) |
0.09%
|
$0.13 | 17,500 |
| 75 | BCAX BICARA THERAPEUTICS INC Since 2026-07-07 | 055477103 | Equity (Common) |
0.01%
|
$0.01 | 650 |
| 76 | EBS Emergent Biosolutions Inc Since 2026-07-07 | 29089Q105 | Equity (Common) |
0.00%
|
$0.00 | 500 |
| 77 | ZYME Zymeworks Inc Since 2026-07-07 | 98985Y108 | Equity (Common) |
0.04%
|
$0.06 | 2,500 |
| 78 | DAWN DAY ONE BIOPHARMACEUTICALS INC Since 2026-07-07 | 23954D109 | Equity (Common) |
0.14%
|
$0.21 | 10,000 |
| 79 | NKTR Nektar Therapeutics Since 2026-07-07 | 640268306 | Equity (Common) |
0.12%
|
$0.18 | 2,500 |
| 80 | OPCH Option Care Health Inc Since 2026-07-07 | 68404L201 | Equity (Common) |
2.28%
|
$3.38 | 125,500 |
| 81 | WAY Waystar Holding Corp Since 2026-07-07 | 946784105 | Equity (Common) |
0.24%
|
$0.36 | 15,000 |
| 82 | IMNM Immunome Inc Since 2026-07-07 | 45257U108 | Equity (Common) |
0.13%
|
$0.19 | 8,500 |
| 83 | PGNY Progyny Inc Since 2026-07-07 | 74340E103 | Equity (Common) |
0.00%
|
$0.00 | 100 |
| 84 | IONS Ionis Pharmaceuticals, Inc. Since 2026-07-07 | 462222100 | Equity (Common) |
0.09%
|
$0.14 | 1,800 |
| 85 | LW Lamb Weston Holdings Inc Since 2026-07-07 | 513272104 | Equity (Common) |
0.29%
|
$0.42 | 10,000 |
| 86 | IMVT Immunovant Inc Since 2026-07-07 | 45258J102 | Equity (Common) |
0.08%
|
$0.12 | 5,000 |
| 87 | CELC Celcuity Inc. Since 2026-07-07 | 15102K100 | Equity (Common) |
0.12%
|
$0.17 | 1,500 |
| 88 | DXCM DexCom Inc Since 2026-07-07 | 252131107 | Equity (Common) |
0.06%
|
$0.08 | 1,300 |
| 89 | GRAL GRAIL Inc Since 2026-07-07 | 384747101 | Equity (Common) |
0.04%
|
$0.06 | 1,200 |
| 90 | ATRC Atricure Inc Since 2026-07-07 | 04963C209 | Equity (Common) |
0.04%
|
$0.06 | 2,000 |
| 91 | ZBH Zimmer Biomet Holdings Inc Since 2026-07-07 | 98956P102 | Equity (Common) |
1.62%
|
$2.40 | 26,500 |
| 92 | EVH Evolent Health, Inc. Since 2026-07-07 | 30050B101 | Equity (Common) |
0.17%
|
$0.24 | 107,500 |
| 93 | RPRX Royalty Pharma PLC Since 2026-07-07 | — | Equity (Common) |
0.10%
|
$0.14 | 3,000 |
| 94 | GH Guardant Health Inc Since 2026-07-07 | 40131M109 | Equity (Common) |
0.03%
|
$0.05 | 500 |
| 95 | IDXX IDEXX Laboratories Inc. Since 2026-07-07 | 45168D104 | Equity (Common) |
0.02%
|
$0.04 | 65 |
| 96 | SPRY ARS Pharmaceuticals Inc Since 2026-07-07 | 82835W108 | Equity (Common) |
0.03%
|
$0.04 | 5,000 |
| 97 | NBIX Neurocrine Biosciences Inc Since 2026-07-07 | 64125C109 | Equity (Common) |
0.01%
|
$0.01 | 100 |
| 98 | ABBV AbbVie Inc. Since 2026-07-07 | 00287Y109 | Equity (Common) |
3.51%
|
$5.20 | 23,900 |
| 99 | ANNX Annexon Inc Since 2026-07-07 | 03589W102 | Equity (Common) |
0.00%
|
$0.01 | 1,000 |
| 100 | SYK Stryker Corporation Since 2026-07-07 | 863667101 | Equity (Common) |
1.07%
|
$1.58 | 4,800 |
| 101 | DVA Davita Inc Since 2026-07-07 | 23918K108 | Equity (Common) |
0.52%
|
$0.77 | 5,000 |
| 102 | MDLZ Mondelez International Inc. Since 2026-07-07 | 609207105 | Equity (Common) |
0.51%
|
$0.75 | 13,000 |
| 103 | ILMN Illumina Inc Since 2026-07-07 | 452327109 | Equity (Common) |
0.31%
|
$0.46 | 3,700 |
| 104 | KALV KalVista Pharmaceuticals Inc. Since 2026-07-07 | 483497103 | Equity (Common) |
0.06%
|
$0.09 | 4,500 |
| 105 | CHE Chemed Corporation Since 2026-07-07 | 16359R103 | Equity (Common) |
1.66%
|
$2.46 | 6,500 |
| 106 | BRKR Bruker Corporation Since 2026-07-07 | 116794108 | Equity (Common) |
0.05%
|
$0.07 | 2,000 |
| 107 | INSP Inspire Medical Systems Inc Since 2026-07-07 | 457730109 | Equity (Common) |
0.05%
|
$0.08 | 1,500 |
| 108 | RLAY Relay Therapeutics Inc Since 2026-07-07 | 75943R102 | Equity (Common) |
0.08%
|
$0.12 | 12,000 |
| 109 | PFE Pfizer Inc. Since 2026-07-07 | 717081103 | Equity (Common) |
0.61%
|
$0.90 | 32,100 |
| 110 | ICUI ICU Medical Inc Since 2026-07-07 | 44930G107 | Equity (Common) |
0.87%
|
$1.29 | 10,000 |
| 111 | HNGE HINGE HEALTH INC Since 2026-07-07 | 433313103 | Equity (Common) |
0.12%
|
$0.17 | 4,500 |
| 112 | EVMN EVOMMUNE INC Since 2026-07-07 | 30054Y107 | Equity (Common) |
0.07%
|
$0.11 | 4,750 |
| 113 | PSNL Personalis Inc Since 2026-07-07 | 71535D106 | Equity (Common) |
0.00%
|
$0.00 | 500 |
| 114 | VMD VIEMED HEALTHCARE INC Since 2026-07-07 | 92663R105 | Equity (Common) |
0.53%
|
$0.78 | 85,000 |
| 115 | NVO Novo Nordisk A/S Since 2026-07-07 | 670100205 | Equity (Common) |
0.00%
|
$0.00 | 100 |
| 116 | HALO Halozyme Therapeutics Inc Since 2026-07-07 | 40637H109 | Equity (Common) |
1.89%
|
$2.79 | 43,200 |
| 117 | SGRY Surgery Partners Inc Since 2026-07-07 | 86881A100 | Equity (Common) |
0.37%
|
$0.55 | 45,697 |
| 118 | MAZE Maze Therapeutics Inc Since 2026-07-07 | 578784100 | Equity (Common) |
0.00%
|
$0.00 | 100 |
| 119 | ELV Elevance Health Inc. Since 2026-07-07 | 036752103 | Equity (Common) |
0.54%
|
$0.79 | 2,710 |
| 120 | COGT COGENT BIOSCIENCES INC Since 2026-07-07 | 19240Q201 | Equity (Common) |
0.09%
|
$0.14 | 3,500 |
| 121 | SLNO Soleno Therapeutics Inc Since 2026-07-07 | 834203309 | Equity (Common) |
0.11%
|
$0.16 | 4,750 |
Frequently Asked Questions — Gabelli Healthcare & WellnessRx Trust
What type of mutual fund is Gabelli Healthcare & WellnessRx Trust?
Gabelli Healthcare & WellnessRx Trust is a SEC-registered Equity fund, with $148M in assets under management.
Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate.
As of its latest SEC N-PORT filing, Gabelli Healthcare & WellnessRx Trust holds 121 portfolio positions, all detailed in the holdings table on this page.
What are Gabelli Healthcare & WellnessRx Trust's assets under management (AUM)?
Gabelli Healthcare & WellnessRx Trust has $148M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting.
AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale.
AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are Gabelli Healthcare & WellnessRx Trust's top holdings?
According to Gabelli Healthcare & WellnessRx Trust's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include
Regeneron Pharmaceuticals, Inc.,
Charles River Laboratories International, Inc.,
Thermo Fisher Scientific Inc
, among others.
The complete list of all 121 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above.
Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is Gabelli Healthcare & WellnessRx Trust's expense ratio?
Expense ratio data for Gabelli Healthcare & WellnessRx Trust is not currently available in StockSifting's database.
The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors.
For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find Gabelli Healthcare & WellnessRx Trust's SEC filings?
Gabelli Healthcare & WellnessRx Trust is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001391437.
You can access all of Gabelli Healthcare & WellnessRx Trust's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on
SEC EDGAR (CIK: 0001391437).
N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is Gabelli Healthcare & WellnessRx Trust's holdings data on StockSifting?
Holdings data for Gabelli Healthcare & WellnessRx Trust on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing.
Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions.
The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released.
For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.